Thermo Fisher Scientific's instruments, equipment, software, services and consumables address a range of needs from sample, ...

Veterinary Molecular Diagnostics MarketThe global veterinary molecular diagnostics market is expected to experience ...

The 3D cell culture industry is poised for substantial growth from 2025 to 2035, driven by advancements in biotechnology and ...

The Parnassus Growth Equity Fund returned 4.85% (net) for Q4 2024, underperforming the Russell 1000 Growth Index’s 7.07%.

MENLO PARK, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2024. Revenue of $39.2 million, a 33% ...

The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...

Compelling clinical results for GLPG5101 in three NHL indications underscore potential of innovative decentralized cell therapy platform to ...

Shares of Thermo Fisher Scientific Inc. TMO slipped 1.65% to $523.09 Tuesday, on what proved to be an all-around great ...

Thermo Fisher Scientific TMO Get Free Report has outperformed the market over the past 15 years by 5.16% on an annualized ...

Thermo Fisher Scientific has been recognized as a star player in the laboratory informatics market on the 360Quadrants ...

This was the stock's fifth consecutive day of losses.